Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics, Inc. - Common Stock
(NQ:
SRPT
)
16.62
-0.18 (-1.04%)
Streaming Delayed Price
Updated: 10:03 AM EDT, May 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sarepta Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
November 14, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
November 11, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
November 05, 2025
Via
Benzinga
Analyst Ratings Send Ripples Through Markets: Sarepta's Resilience vs. Pinterest's Plunge
November 05, 2025
The financial markets are a complex ecosystem, constantly reacting to a myriad of inputs, from macroeconomic data to geopolitical shifts. Among the most closely watched catalysts are the pronouncements...
Via
MarketMinute
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback
↗
November 03, 2025
Via
Stocktwits
This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
↗
November 05, 2025
Via
Benzinga
Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial
November 04, 2025
Sarepta Therapeutics Inc. (NASDAQ: SRPT) experienced a dramatic downturn in its stock valuation today, November 4, 2025, following the announcement of disappointing results from a pivotal late-stage...
Via
MarketMinute
Topics
Death
Which stocks are experiencing notable movement on Tuesday?
↗
November 04, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Earnings Scheduled For November 3, 2025
↗
November 03, 2025
Via
Benzinga
A Peek at Sarepta Therapeutics's Future Earnings
↗
October 31, 2025
Via
Benzinga
Gold Falls Over 1%; Uber Shares Decline After Q3 Results
↗
November 04, 2025
Via
Benzinga
Sarepta Faces Investor Skepticism As Duchenne Data Falls Short Of Statistical Significance
↗
November 04, 2025
Sarepta's Duchenne trial missed its main goal but showed trends favoring treatment; Q3 earnings topped estimates amid Elevidys sales weakness.
Via
Benzinga
Tuesday's session: top gainers and losers
↗
November 04, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Sarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
↗
November 04, 2025
Enough though Sarepta shares are crashing, "Pharma Bro" Martin Shkreli says he still likes the stock.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 04, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
November 04, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 04, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
↗
November 04, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 04, 2025
Via
Benzinga
Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch
↗
November 04, 2025
While Dow Jones futures were down by 0.72% at the time of writing, the S&P 500 futures fell 1.02%.
Via
Stocktwits
Topics
ETFs
Stocks
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
↗
November 04, 2025
Via
Benzinga
Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why
↗
November 03, 2025
Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.
Via
Benzinga
These stocks are moving in today's after hours session
↗
November 03, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests
↗
November 03, 2025
Sarepta stock crashed Monday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 03, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More
↗
November 03, 2025
Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.
Via
Benzinga
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
October 27, 2025
From
Sarepta Therapeutics, Inc.
Via
Business Wire
Tradr Unleashes 2X Single-Stock Gold ETFs, Reshaping Short-Term Gold Investment Landscape
October 23, 2025
New York, NY – October 23, 2025 – Tradr, a prominent innovator in the Exchange-Traded Fund (ETF) market, has today significantly expanded its product suite with the launch of nine new single-stock 2X...
Via
MarketMinute
Topics
Artificial Intelligence
Derivatives
ETFs
Tradr Launches 9 Single-Stock 2X ETFs With First-Of-Its-Kind OpenDoor, Gold And AI Exposure
↗
October 23, 2025
The new ETFs include the first-of-their-kind gold and AI plays, giving traders targeted exposure without using margin or complex options.
Via
Benzinga
Topics
Artificial Intelligence
ETFs
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
